Published On:June 1 2023
Story Viewed 165 Times

Laurus Labs invests Rs. 80 crore in cell & gene therapy firm ImmunoACT.

Laurus Labs on Wednesday invested further Rs 80 crore in the Immunoadoptive Cell Therapy Private Ltd. (lmmunoACT), that's developing an affordable CAR T-cell therapy for curing specific types of blood cancers.

Laurus will get an additional stake of 7.24% in ImmunoACT, as part of Series-B funding. Post the completion of the latest round of funding, Laurus stake in ImmunoACT will increase to 33.86% (on a fully diluted basis).


OUR OTHER PRODUCTS & SERVICES: Projects Database | Tenders Database | About Us | Contact Us | Terms of Use | Advertise with Us | Privacy Policy | Disclaimer | Feedback

This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2023

Technology Partner - Pairscript Software